Optimizing use of GLP-1 receptor agonists: safety, tolerability, adherence, and patient selection in cardiovascular practice
Year: 2026
Type: article
Institutions: University of Kragujevac, Clinical Centre of Kragujevac
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, cardiovascular risk reduction, obesity, heart failure, major adverse cardiovascular events, gastrointestinal adverse effects, medication adherence, patient selection, dose titration, type 2 diabetes, atherosclerotic cardiovascular disease, drug safety, financial burden
Open Access status: closed
OpenAlex ID: W7234850217
